Back to Search
MICHAEL SAVIN, DMD
DMD
Periodontics
NPI: 1891901823Individual
Specialties, Licenses & Credentials
PeriodonticsPrimary
Dentist — Periodontics
Code: 1223P0300X
26090(NY)
Research & Publications (20)
Spectroscopic investigations of the binding interaction of a new indanedione derivative with human and bovine serum albumins.
PMID 19396020·Molecules·2009
7-preclinical
Radiation microsphere-induced GI ulcers after selective internal radiation therapy for hepatic tumors: an underrecognized clinical entity.
PMID 19577743·Gastrointest Endosc·2009
8-other
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
PMID 19204201·J Clin Oncol·2009
3-trial
Mycophenolate mofetil in high-risk patients with primary glomerulonephritis: results of a 1-year prospective study.
PMID 19194109·Nephron Clin Pract·2009
4-observational
Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.
PMID 19157721·Int J Radiat Oncol Biol Phys·2009
4-observational
Pemetrexed in relapsed small-cell lung cancer and the impact of shortened vitamin supplementation lead-in time: results of a phase II trial.
PMID 18978567·J Thorac Oncol·2008
3-trial
Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes.
PMID 18269774·Clin Breast Cancer·2007
3-trial
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.
PMID 17135639·J Clin Oncol·2006
3-trial
Regional yttrium-90 microsphere treatment of surgically unresectable and chemotherapy-refractory metastatic liver carcinoma.
PMID 16999596·Cancer Biother Radiopharm·2006
3-trial
Peritoneal ports for treatment of intractable ascites.
PMID 15758132·J Vasc Interv Radiol·2005
8-other
Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging.
PMID 16105922·J Vasc Interv Radiol·2005
8-other
Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.
PMID 15748464·Clin Breast Cancer·2005
3-trial
Links between phytoplankton and bacterial community dynamics in a coastal marine environment.
PMID 15688258·Microb Ecol·2005
4-observational
Plankton diversity in the Bay of Fundy as measured by morphological and molecular methods.
PMID 15164237·Microb Ecol·2004
4-observational
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer.
PMID 11821454·J Clin Oncol·2002
3-trial
Adjuvant chemotherapy with doxorubicin and cyclophosphamide in women with rapidly proliferating node-negative breast cancer.
PMID 12123539·Clin Breast Cancer·2002
3-trial
Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer.
PMID 12123336·Ann Oncol·2002
3-trial
Placement of vena cava filters: factors affecting technical success and immediate complications.
PMID 12185026·AJR Am J Roentgenol·2002
8-other
The significance of apoptosis for early diagnosis of Balkan nephropathy.
PMID 11568234·Nephrol Dial Transplant·2001
6-review
Low proliferative rate of invasive node-negative breast cancer predicts for a favorable outcome: a prospective evaluation of 669 patients.
PMID 11899353·Clin Breast Cancer·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 153 N BROADWAY
NYACK, NY 10960 - Phone
- (845) 358-5222
Quick Facts
- NPI
- 1891901823
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile